Treating cervical cancer patients with both radiotherapy and drugs can reduce the risk of dying by almost a quarter, research has found.
By Rebecca Smith, Medical Editor
Published: 7:30AM BST 20 Aug 2010
An audit of patients treated in British cancer centres in 2001 and 2002 found those who received both chemotherapy and radiotherapy did better than those who were just treated with radiotherapy.
The audit was published by The Royal College of Radiologists...
The PA Breast Cancer Coalition Announces Request for Applications for Income Tax Research Grants
EPHRATA, Pa., Aug. 19 /PRNewswire-USNewswire/ -- Are you a breast or cervical cancer researcher in PA looking for additional research funding? The PA Breast Cancer Coalition (PBCC) is awaiting your grant application for the PBCC's Income Tax Refunds for Breast and Cervical Cancer Research Grants. The grant funding cycle is July 1, 2011– June 30, 2012.
No Adverse Side Effects Were Observed After Initial Nine Doses
NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has completed the nine (9) doses to be administered to the three (3) vanguard patients in the low dose group of its phase II cervical dysplasia clinical trial study.
We cannot escape the realities of biology. Just as children rescued from leukemia and lymphoma live to grow into adults who must confront the adverse effects of their curative treatment, people rescued from AIDS by HAART (highly active antiretroviral therapy) are showing a substantially increased risk of cancers other than the "AIDS-defining" malignancies designated by the Centers for Disease Control in the 1980s: Kaposi sarcoma, non-Hodgkin lymphoma (NHL),...
Augmenix Announces First Commercial Use of SpaceOAR™ System for Prostate-Rectum Separation in Prostate Cancer Patients Undergoing Radiation Therapy
WALTHAM, Mass., Aug. 11 /PRNewswire/ -- Augmenix, Inc. announced today that Prof. Michael Eble and Dr. Michael Pinkawa of the Aachen University Hospital, Aachen, Germany, performed a commercial implantation of the company's CE Mark approved SpaceOAR™ System. The SpaceOAR hydrogel (from spacing Organs At Risk) is designed to be a tissue...
